Unknown

Dataset Information

0

Neonatal Bacillus Calmette-Guerin Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial.

ABSTRACT:

SUBMITTER: Pittet LF 

PROVIDER: S-EPMC12666751 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Bacillus Calmette-Guerin vaccination using a microneedle patch.
| S-EPMC3127204 | biostudies-literature
Unknown Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guerin vaccination.
| S-EPMC8342465 | biostudies-literature
Unknown Effectiveness of bacillus Calmette-Guerin vaccination history on pulmonary tuberculosis symptoms.
| S-EPMC6879972 | biostudies-literature
Methylation profiling Epigenome-Wide Association Study of Bacillus Calmette Guerin vaccination in human circulating monocytes
2022-08-02 | GSE168779 | GEO
Unknown The impact of Bacillus Calmette-Guerin vaccination on antibody response after COVID-19 vaccination.
| S-EPMC10583058 | biostudies-literature
Unknown Bacillus Calmette-Guerin vaccination, thymic size, and thymic output in healthy newborns.
| S-EPMC5605675 | biostudies-literature
Unknown 100 years of Bacillus Calmette-Guerin immunotherapy: from cattle to COVID-19.
| S-EPMC8204595 | biostudies-literature
Unknown Bacillus Calmette-Guerin (BCG): the adroit vaccine.
| S-EPMC7921379 | biostudies-literature
Unknown T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette-Guerin Vaccination.
| S-EPMC7939042 | biostudies-literature
Unknown Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer.
| S-EPMC9543886 | biostudies-literature